Abstract
Heart failure (HF) is a condition with high mortality worldwide characterized by persistent progression. Myocardial hypertrophy is a dominant feature during the early stage of HF. The development of HF is a complex process related to a series of physiologic and molecular factors. Although the treatment of HF has been changed during the past century, the knowledge on its molecular mechanism is still very limited. The review herein tries to touch the molecular basis underlying HF and discusses the relevance between HF and other diseases such as thrombosis. Furthermore, we believe that the global alterations during progression of HF revealed by high content screening techniques may facilitate our understanding on HF, and thereby the development of new therapeutics with less side effect.
Keywords: Extracellular matrix, heart failure, integrin, myocardial hypertrophy, signaling pathway, and thrombosis.
Current Protein & Peptide Science
Title:Outline of Proteins and Signaling Pathways Involved in Heart Failure
Volume: 13 Issue: 7
Author(s): Qun Bi
Affiliation:
Keywords: Extracellular matrix, heart failure, integrin, myocardial hypertrophy, signaling pathway, and thrombosis.
Abstract: Heart failure (HF) is a condition with high mortality worldwide characterized by persistent progression. Myocardial hypertrophy is a dominant feature during the early stage of HF. The development of HF is a complex process related to a series of physiologic and molecular factors. Although the treatment of HF has been changed during the past century, the knowledge on its molecular mechanism is still very limited. The review herein tries to touch the molecular basis underlying HF and discusses the relevance between HF and other diseases such as thrombosis. Furthermore, we believe that the global alterations during progression of HF revealed by high content screening techniques may facilitate our understanding on HF, and thereby the development of new therapeutics with less side effect.
Export Options
About this article
Cite this article as:
Bi Qun, Outline of Proteins and Signaling Pathways Involved in Heart Failure, Current Protein & Peptide Science 2012; 13 (7) . https://dx.doi.org/10.2174/138920312804142084
DOI https://dx.doi.org/10.2174/138920312804142084 |
Print ISSN 1389-2037 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5550 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Interstitial Lung Disease in Systemic Lupus Erythematosus, Sjogren’s Syndrome, and Mixed Connective Tissue Disease
Current Respiratory Medicine Reviews Hemodynamic Assessment and In vivo Catabolism of Adenosine 5’-triphosphate in Doxorubicin or Isoproterenol-induced Cardiovascular Toxicity
Drug Metabolism Letters Endothelial Effects of Drugs Designed to Treat Erectile Dysfunction
Current Pharmaceutical Design Left Ventricular Hypertrophy in ADPKD: Changing Demographics
Current Hypertension Reviews Genetic Aspects of Lone Atrial Fibrillation: What Do We Know?
Current Pharmaceutical Design Advances in Therapy for Psoriasis: An Overview of Infliximab, Etanercept, Efalizumab, Alefacept, Adalimumab, Tazarotene, and Pimecrolimus
Current Pharmaceutical Design <i>Uncaria tomentosa</i> (Willd. ex Schult.): Focus on Nutraceutical Aspects
Current Bioactive Compounds Novel Therapeutic Strategy in the Management of COPD: A Systems Medicine Approach
Current Medicinal Chemistry Construction, Expression, Purification and Immunology Effect of an Antiatherosclerosis Chimeric Enzyme Vaccine in Escherichia coli
Protein & Peptide Letters The Cardiac Microvasculature in Hypertension, Cardiac Hypertrophy and Diastolic Heart Failure
Current Vascular Pharmacology Kinase CK2 Inhibition: An Update
Current Medicinal Chemistry The Effects of Obesity on the Cerebral Vasculature
Current Vascular Pharmacology Arterial Stiffness, Cognitive Dysfunction and Adherence to Antihypertensive Agents. Is there a Link to Hypertensive Patients?
Current Vascular Pharmacology Cardiac Side Effects of Chemotherapy: State of Art and Strategies for a Correct Management
Current Vascular Pharmacology Older and Newer Strategies for the Pharmacological Management of Agitation in Patients with Bipolar Disorder or Schizophrenia
CNS & Neurological Disorders - Drug Targets Ca<sup>2+</sup> Signalling in Endothelial Progenitor Cells: A Novel Means to Improve Cell-Based Therapy and Impair Tumour Vascularisation
Current Vascular Pharmacology Cytokine and Nitric Oxide Production Following Severe Envenomation
Current Drug Targets - Inflammation & Allergy Circulating Endothelial Progenitor Cells Characterization, Function and Relationship with Cardiovascular Risk Factors
Current Pharmaceutical Design Stem Cell Therapy for the Treatment of Myocardial Infarction
Current Pharmaceutical Design Pregnane X Receptor and its Potential Role in Drug Resistance in Cancer Treatment
Recent Patents on Anti-Cancer Drug Discovery